Star Health and Allied Insurance reported a claims ratio of 69% in the second quarter of fiscal year 2027, marking five consecutive quarters of improvement. These operational efficiency gains have led to brokerage projections of potential profit growth, though investors remain focused on sector-wide competitive pricing pressures.
Star Health and Allied Insurance posted its performance results for the second quarter of the 2027 fiscal year, revealing an improvement in key operational metrics. The company reported a claims ratio of 69%, a figure that has seen a consistent decline over the past five quarters. This ratio represents the percentage of premiums collected that the insurer pays out as claims. A lower claims ratio generally suggests that the company is effectively managing its underwriting risks and claim settlements.
The insurer’s combined ratio, which is a broader measure of profitability in the insurance industry, stood at 98%. This ratio combines the claims ratio with other operating and administrative expenses. A combined ratio below 100% indicates that the insurer is generating an underwriting profit, meaning the premiums collected are higher than the claims and expenses paid out. For an insurance provider like Star Health, maintaining this ratio below the 100% mark is a critical indicator of financial health and disciplined business practices.
Following these results, analysts at Emkay Global Financial have updated their outlook on the company, setting a price target of Rs 700. The brokerage firm noted that the company’s recent performance reflects a shift toward more disciplined portfolio management and better geographical selection. These strategic changes are aimed at improving long-term profitability even as the company continues to scale its operations. While growth in fresh business is projected to continue at around 20%, management has signaled that the pace of growth might moderate in the second half of the year due to the high base effect from the previous year.
The health insurance sector in India is characterized by intense competition. Companies are frequently balancing the need to gain market share with the need to maintain underwriting discipline. Healthcare inflation, which refers to the rising cost of medical services and treatments, remains a significant factor for all players in this space. If medical costs rise faster than the premiums charged, insurance companies can face pressure on their profit margins. Consequently, investors often monitor how efficiently a company can re-price its products and manage its hospital network relationships to offset these rising costs.
Looking ahead, the sustainability of these improved operational ratios will likely be a primary monitorable for investors. While the trend over the last several quarters has been positive, the ability to maintain these levels will depend on the company's success in navigating competitive pricing strategies and managing claims as the insurance book grows. Market participants will also look for management commentary in future earnings calls regarding the impact of sector-wide competitive dynamics on their ability to maintain these efficiency gains.